Peer-reviewedCC BYMedicina (Kaunas, Lithuania)
Polydeoxyribonucleotide (PDRN) in Osteoarthritis: Immunomodulatory and Matrix-Supportive Potential, A2A Receptor-Associated Mechanisms, and Translational Challenges
Related
- Celastrol in Rheumatoid Arthritis: Immunomodulatory Mechanisms, Multicellular Convergence, and Translational Challenges
- Immunomodulatory potential of Mongolian medicine in sepsis: current evidence, challenges, and translational perspectives
- Immunomodulatory strategies for ex vivo immune cell expansion in adoptive cell therapy: translational and regulatory considerations for clinical manufacturing
- Assessing the translational value of animal models in developing pain-targeting therapies for clinical osteoarthritis
- Functional peptide therapeutics for veterinary osteoarthritis: mechanisms, delivery systems, and translational priorities
BibTeX
@article{anon2026polydeoxyribonucleotide,
title = {{Polydeoxyribonucleotide (PDRN) in Osteoarthritis: Immunomodulatory and Matrix-Supportive Potential, A2A Receptor-Associated Mechanisms, and Translational Challenges}},
journal = {Medicina (Kaunas, Lithuania)},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13706838},
note = {CC BY},
}
RIS
TY - JOUR
TI - Polydeoxyribonucleotide (PDRN) in Osteoarthritis: Immunomodulatory and Matrix-Supportive Potential, A2A Receptor-Associated Mechanisms, and Translational Challenges
PY - 2026
DA - 2026/09/23
JO - Medicina (Kaunas, Lithuania)
UR - https://europepmc.org/article/PMC/PMC13706838
SN - 1010-660X
SN - 1648-9144
ER -